AnGes, Inc.

AMGXFOTCHealthcare● Active

$0.36

+$0.00(+0.00%)

Market Cap$142504592

P/E Ratio—

52W High$0.3602

52W Low$0.3353

Avg Volume515.832

Open$0.34

Beta0.65

Free Cash Flow Financials Revenue

AnGes, Inc. (AMGXF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

AMGXF · free cash flow · updated Jun 9, 2026

Core FCF metrics

AMGXF · FCF · TTM · margin & CAGR

Free cash flow was −$5.77B for FY2025 (fiscal year ending 2025-12-31), up 13.8% year-over-year The FCF margin was -659.5%.

FY2025 Free Cash Flow−$5.77B▲ +13.8% YoY

Trailing 12M (TTM)$0trailing 4 quarters sum

FCF Margin-659.5%−$5.77B ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

AMGXF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$5.76B(14M)−$5.77B▲ +13.8%-659.5%

FY2024−$6.61B(77M)−$6.69B▲ +24.3%—

FY2023−$8.75B(89M)−$8.84B▲ +21.4%—

FY2022−$11.21B(20M)−$11.23B▲ +2.0%—

FY2021−$11.38B(80M)−$11.46B▼ 276.7%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

AMGXF · P/FCF · FCF yield · FCF per share

AnGes, Inc. (AMGXF) reported negative free cash flow of −$5.77B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

AMGXF · cash flow statement · operating / investing / financing

For FY2025, AnGes, Inc. generated −$5.76B in operating cash flow and spent 14M in capital expenditures, yielding −$5.77B in free cash flow.

Operating Activities

−$5.76B

Cash from core business operations

2025-12-31

Investing Activities

+$18.5M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$5.91B

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$5.76B) − |CapEx| (14M) = FCF (−$5.77B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

AMGXF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

AnGes, Inc.YOU

AMGXF

−$5.77B+13.8%-659.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

AnGes, Inc. (AMGXF) reported free cash flow of −$5.77B for FY2025 (fiscal year ending 2025-12-31), up 13.8% year-over-year. The FCF margin was -659.5%.

AnGes, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

AMGXF free cash flow · 8 questions

AnGes, Inc. free cash flow was −$5.77B for FY2025, up 13.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $0.

AMGXF free cash flowAMGXF FCFAMGXF FCF 2025AMGXF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · AnGes, Inc. · AnGes, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026